Jag Janki Pharma Private Limited
About Jag Janki Pharma Private Limited
Data last updated:
Jag Janki Pharma Private Limited is a private limited company based in Delhi, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 18 May 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2011PTC219388. Its GSTIN is 10AACCJ5969Q1Z1 (Bihar).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Pushpa Devi Thakur and Sushil Kumar Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 107 Kh. No. 14/1/2 Gali No. 3 A – 1 Block Kamal Vihar Burari, Delhi, India – 110084.
As per the financials filed for FY 2025, the company reported a revenue of ₹12.67 Lakh, a growth of 3% compared to the previous year. For the same year it recorded a net loss of ₹10,295 (net margin -0.8%) and EBITDA of -₹11,294 (EBITDA margin -0.9%). Revenue has declined at a compounded annual rate (CAGR) of 1% over three years and 36% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Jag Janki Pharma Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address107 Kh. No. 14/1/2 Gali No. 3 A – 1 Block Kamal Vihar Burari, Delhi, India – 110084
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Jag Janki Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Jag Janki Pharma Private Limited
FY 2025 filings availableJag Janki Pharma Private Limited reported revenue of ₹12.67 Lakh (up 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 3% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 36%. EBITDA rose 97% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹11,294 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹10,295 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.9% | ||||
| Net Profit Margin | -0.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Jag Janki Pharma Private Limited, buy the company report.
Board of directors of Jag Janki Pharma Private Limited
Jag Janki Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pushpa Devi Thakur Also directs: Hecure Agro Plants Private Limited, Hecure Herbs Private Limited, Shecure Laboratories Private Limited and 5 more | Director | 18 May 2011 | 15 Years 5 Months | Current |
| Sushil Kumar Singh | Director | 18 May 2011 | 15 Years 5 Months | Current |
Auditor
Jag Janki Pharma Private Limited is audited by SHOBHAGPRASADAGARWAL for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SHOBHAGPRASADAGARWAL | FY 2017 | 092194 |
Shareholding
The shareholding of Jag Janki Pharma Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Jag Janki Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Jag Janki Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Jag Janki Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Jag Janki Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AACCJ5969Q1Z1 | Bihar | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Jag Janki Pharma Private Limited, buy the company report.
Recent activity
Jag Janki Pharma Private Limited has 2 board changes on record since 2011: 2 appointments. The latest: Pushpa Devi Thakur was appointed as Director on 18 May 2011.
Frequently asked questions
Jag Janki Pharma is an active private limited company based in Delhi, India. The company works in other wholesale, within the trading industry. It was incorporated on 18 May 2011 (15+ years old) and is registered under CIN U51909DL2011PTC219388.
Jag Janki Pharma has 2 current directors:
- Pushpa Devi Thakur - Director
- Sushil Kumar Singh - Director
The latest financial statements of Jag Janki Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Jag Janki Pharma is 10AACCJ5969Q1Z1, registered in Bihar.
The CIN (Corporate Identification Number) of Jag Janki Pharma is U51909DL2011PTC219388. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Jag Janki Pharma was incorporated on 18 May 2011, making it 15+ years old. It is registered with the Registrar of Companies, Delhi.
Pushpa Devi Thakur was appointed as Director on 18 May 2011. Sushil Kumar Singh was appointed as Director on 18 May 2011.
The registered office of Jag Janki Pharma is at 107 Kh. No. 1412 Gali No. 3 A – 1 Block Kamal Vihar Burari, Delhi, India – 110084.
Jag Janki Pharma operates in the trading industry, in the other wholesale segment.
The compliance status of Jag Janki Pharma is compliant as of 10 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
